Pharma Mar S.A. (PHM) — Cash Flow Quality Index
Pharma Mar S.A. (PHM) has a Cash Flow Quality Index of 0.56x as of December 2025. Operating cash flow of €33.58 Million is below net income of €59.66 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore long-term investment intensity of Pharma Mar S.A. to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Pharma Mar S.A. Cash Flow Quality Index (2005–2025)
Historical Cash Flow Quality Index for Pharma Mar S.A. across 11 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check PHM tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Pharma Mar S.A. (2005–2025)
Year-by-year earnings quality comparison for Pharma Mar S.A.. For live market cap and the full company financial profile, see how much is Pharma Mar S.A. worth.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.71x | €53.13 Million | €74.99 Million | ▲ +40.9% |
| 2024 | 0.50x | €6.03 Million | €11.98 Million | ▲ +104.3% |
| 2023 | -11.83x | €-13.45 Million | €1.14 Million | ▼ -1451.4% |
| 2022 | 0.88x | €38.32 Million | €43.79 Million | ▲ +224.2% |
| 2021 | 0.27x | €25.68 Million | €95.13 Million | ▼ -85.9% |
| 2020 | 1.92x | €278.94 Million | €145.61 Million | ▲ +2.0% |
| 2015 | 1.88x | €11.10 Million | €5.91 Million | ▲ +22.4% |
| 2014 | 1.54x | €22.11 Million | €14.40 Million | ▲ +23.0% |
| 2013 | 1.25x | €16.34 Million | €13.09 Million | ▲ +133.2% |
| 2011 | -3.76x | €-4.28 Million | €1.14 Million | ▲ +99.5% |
| 2005 | -786.52x | €-33.03 Million | €42.00K | — |